Michael Egholm - 04 Apr 2022 Form 4 Insider Report for STANDARD BIOTOOLS INC. (LAB)

Reporting relationship: President & CEO, Director
Issuer ticker: LAB
Reported as of: 04 Apr 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 06 Apr 2022, 18:35:59 UTC
Prior SEC filing: 07 Oct 2021
Next SEC filing: 21 Jun 2022
Source filing: View source filing
Reporting owner signature: /s/ Michael Egholm by Nicholas Khadder, Attorney-in-Fact

Key filing fact

Michael Egholm filed Form 4 for STANDARD BIOTOOLS INC. (LAB) on 06 Apr 2022.

Key facts

This page summarizes Michael Egholm's Form 4 filing for STANDARD BIOTOOLS INC. (LAB).
2 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 06 Apr 2022, 18:35.

Change

Previous filing in this sequence was filed on 07 Oct 2021.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

LAB transaction Derivative

Restricted Stock Units

Award

Transaction value: $0
Shares: +786,049
Change %
Price: $0.000000
Shares after: 786,049
Date: 04 Apr 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 786,049
Exercise price
Footnotes: F1, F2

LAB transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +4,529,773
Change %
Price: $0.000000
Shares after: 4,529,773
Date: 04 Apr 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 4,529,773
Exercise price: $3.99
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock.

Footnote F2

Restricted Stock Units vest in four equal annual installments beginning April 4, 2023.

Footnote F3

The Option becomes exercisable as to 1/4th of the underlying shares on April 4, 2023, and as to an additional 1/48th of the total number of shares each month thereafter.